Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe

Identifieur interne : 000557 ( PascalFrancis/Corpus ); précédent : 000556; suivant : 000558

Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe

Auteurs : O. Donoso Mantke ; H. Schmitz ; H. Zeller ; P. Heyman ; A. Papa ; M. Niedrig

Source :

RBID : Pascal:06-0073220

Descripteurs français

English descriptors

Abstract

The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 1025-496X
A05       @2 10
A06       @2 4-6
A08 01  1  ENG  @1 Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe
A11 01  1    @1 DONOSO MANTKE (O.)
A11 02  1    @1 SCHMITZ (H.)
A11 03  1    @1 ZELLER (H.)
A11 04  1    @1 HEYMAN (P.)
A11 05  1    @1 PAPA (A.)
A11 06  1    @1 NIEDRIG (M.)
A17 01  1    @1 Robert Koch Institut. Berlin. @3 DEU
A17 02  1    @1 Bernhard Nocht Institute for Tropical Medicine. Department of Virology. Hambourg. @3 DEU
A17 03  1    @1 Institut Pasteur. Unité Biologie des Infections Virales Emergentes. Lyon. @3 FRA
A17 04  1    @1 Queen Astrid Military Hospital. Research Laboratory for Vector-Borne Diseases. Bruxelles. @3 BEL
A17 05  1    @1 Aristotelian University of Thessaloniki. School of Medicine. Department of Microbiology. Thessaloniki. @3 GRC
A20       @1 102-106 @3 3 tabl.
A21       @1 2005-04
A23 01      @0 ENG
A43 01      @1 BDSP/InVS
A44       @0 8800
A45       @0 38 ref.
A47 01  1    @0 06-0073220
A60       @1 P
A61       @0 A
A64 01  2    @0 EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY
A66 01      @0 FRA
C01 01    ENG  @0 The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)
C02 01  X    @0 002B30A11
C03 01  X  FRE  @0 Voyage
C03 01  X  ENG  @0 Travel
C03 01  X  SPA  @0 Viaje
C03 02  X  FRE  @0 Virus @2 NW
C03 02  X  ENG  @0 Virus @2 NW
C03 02  X  SPA  @0 Virus @2 NW
C03 03  X  FRE  @0 Réseau
C03 03  X  ENG  @0 Network
C03 03  X  SPA  @0 Red
C03 04  X  FRE  @0 Surveillance sanitaire
C03 04  X  ENG  @0 Sanitary surveillance
C03 04  X  SPA  @0 Vigilancia sanitaria
C03 05  X  FRE  @0 Epidémiologie
C03 05  X  ENG  @0 Epidemiology
C03 05  X  SPA  @0 Epidemiología
C03 06  X  FRE  @0 Qualité
C03 06  X  ENG  @0 Quality
C03 06  X  SPA  @0 Calidad
C03 07  X  FRE  @0 Sérologie
C03 07  X  ENG  @0 Serology
C03 07  X  SPA  @0 Serología
C03 08  X  FRE  @0 Biologie clinique
C03 08  X  ENG  @0 Clinical biology
C03 08  X  SPA  @0 Biología clínica
C03 09  X  FRE  @0 Laboratoire
C03 09  X  ENG  @0 Laboratory
C03 09  X  SPA  @0 Laboratorio
C03 10  X  FRE  @0 Europe @2 NG
C03 10  X  ENG  @0 Europe @2 NG
C03 10  X  SPA  @0 Europa @2 NG
C03 11  X  FRE  @0 Diagnostic
C03 11  X  ENG  @0 Diagnosis
C03 11  X  SPA  @0 Diagnóstico
C03 12  X  FRE  @0 Maladie émergente @2 NM
C03 12  X  ENG  @0 Emerging disease @2 NM
C03 12  X  SPA  @0 Enfermedad emergente @2 NM
N21       @1 044

Format Inist (serveur)

NO : PASCAL 06-0073220 BDSP
ET : Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe
AU : DONOSO MANTKE (O.); SCHMITZ (H.); ZELLER (H.); HEYMAN (P.); PAPA (A.); NIEDRIG (M.)
DT : Publication en série; Niveau analytique
SO : EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY; ISSN 1025-496X; France; Da. 2005-04; Vol. 10; No. 4-6; Pp. 102-106; Bibl. 38 ref.; 3 tabl.
LA : Anglais
EA : The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)
CC : 002B30A11
FD : Voyage; Virus; Réseau; Surveillance sanitaire; Epidémiologie; Qualité; Sérologie; Biologie clinique; Laboratoire; Europe; Diagnostic; Maladie émergente
ED : Travel; Virus; Network; Sanitary surveillance; Epidemiology; Quality; Serology; Clinical biology; Laboratory; Europe; Diagnosis; Emerging disease
SD : Viaje; Virus; Red; Vigilancia sanitaria; Epidemiología; Calidad; Serología; Biología clínica; Laboratorio; Europa; Diagnóstico; Enfermedad emergente
LO : BDSP/InVS
ID : 06-0073220

Links to Exploration step

Pascal:06-0073220

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</title>
<author>
<name sortKey="Donoso Mantke, O" sort="Donoso Mantke, O" uniqKey="Donoso Mantke O" first="O." last="Donoso Mantke">O. Donoso Mantke</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Schmitz, H" sort="Schmitz, H" uniqKey="Schmitz H" first="H." last="Schmitz">H. Schmitz</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Zeller, H" sort="Zeller, H" uniqKey="Zeller H" first="H." last="Zeller">H. Zeller</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Heyman, P" sort="Heyman, P" uniqKey="Heyman P" first="P." last="Heyman">P. Heyman</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Papa, A" sort="Papa, A" uniqKey="Papa A" first="A." last="Papa">A. Papa</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Niedrig, M" sort="Niedrig, M" uniqKey="Niedrig M" first="M." last="Niedrig">M. Niedrig</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0073220</idno>
<date when="2005-04">2005-04</date>
<idno type="stanalyst">PASCAL 06-0073220 BDSP</idno>
<idno type="RBID">Pascal:06-0073220</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000557</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</title>
<author>
<name sortKey="Donoso Mantke, O" sort="Donoso Mantke, O" uniqKey="Donoso Mantke O" first="O." last="Donoso Mantke">O. Donoso Mantke</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Schmitz, H" sort="Schmitz, H" uniqKey="Schmitz H" first="H." last="Schmitz">H. Schmitz</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Zeller, H" sort="Zeller, H" uniqKey="Zeller H" first="H." last="Zeller">H. Zeller</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Heyman, P" sort="Heyman, P" uniqKey="Heyman P" first="P." last="Heyman">P. Heyman</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Papa, A" sort="Papa, A" uniqKey="Papa A" first="A." last="Papa">A. Papa</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Niedrig, M" sort="Niedrig, M" uniqKey="Niedrig M" first="M." last="Niedrig">M. Niedrig</name>
<affiliation>
<wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY</title>
<idno type="ISSN">1025-496X</idno>
<imprint>
<date when="2005-04">2005-04</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY</title>
<idno type="ISSN">1025-496X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Clinical biology</term>
<term>Diagnosis</term>
<term>Emerging disease</term>
<term>Epidemiology</term>
<term>Europe</term>
<term>Laboratory</term>
<term>Network</term>
<term>Quality</term>
<term>Sanitary surveillance</term>
<term>Serology</term>
<term>Travel</term>
<term>Virus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Voyage</term>
<term>Virus</term>
<term>Réseau</term>
<term>Surveillance sanitaire</term>
<term>Epidémiologie</term>
<term>Qualité</term>
<term>Sérologie</term>
<term>Biologie clinique</term>
<term>Laboratoire</term>
<term>Europe</term>
<term>Diagnostic</term>
<term>Maladie émergente</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1025-496X</s0>
</fA01>
<fA05>
<s2>10</s2>
</fA05>
<fA06>
<s2>4-6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>DONOSO MANTKE (O.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SCHMITZ (H.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ZELLER (H.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>HEYMAN (P.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>PAPA (A.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>NIEDRIG (M.)</s1>
</fA11>
<fA17 i1="01" i2="1">
<s1>Robert Koch Institut. Berlin.</s1>
<s3>DEU</s3>
</fA17>
<fA17 i1="02" i2="1">
<s1>Bernhard Nocht Institute for Tropical Medicine. Department of Virology. Hambourg.</s1>
<s3>DEU</s3>
</fA17>
<fA17 i1="03" i2="1">
<s1>Institut Pasteur. Unité Biologie des Infections Virales Emergentes. Lyon.</s1>
<s3>FRA</s3>
</fA17>
<fA17 i1="04" i2="1">
<s1>Queen Astrid Military Hospital. Research Laboratory for Vector-Borne Diseases. Bruxelles.</s1>
<s3>BEL</s3>
</fA17>
<fA17 i1="05" i2="1">
<s1>Aristotelian University of Thessaloniki. School of Medicine. Department of Microbiology. Thessaloniki.</s1>
<s3>GRC</s3>
</fA17>
<fA20>
<s1>102-106</s1>
<s3>3 tabl.</s3>
</fA20>
<fA21>
<s1>2005-04</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>BDSP/InVS</s1>
</fA43>
<fA44>
<s0>8800</s0>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>06-0073220</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="2">
<s0>EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY</s0>
</fA64>
<fA66 i1="01">
<s0>FRA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B30A11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Voyage</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Travel</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Viaje</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Réseau</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Network</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Red</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Surveillance sanitaire</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Sanitary surveillance</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Vigilancia sanitaria</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Epidémiologie</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Epidemiology</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Epidemiología</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Qualité</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Quality</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Calidad</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Sérologie</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Serology</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Serología</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Biologie clinique</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Clinical biology</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Biología clínica</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Laboratoire</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Laboratory</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Laboratorio</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Europe</s0>
<s2>NG</s2>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Europe</s0>
<s2>NG</s2>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Europa</s0>
<s2>NG</s2>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Diagnostic</s0>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Diagnosis</s0>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Diagnóstico</s0>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Maladie émergente</s0>
<s2>NM</s2>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Emerging disease</s0>
<s2>NM</s2>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Enfermedad emergente</s0>
<s2>NM</s2>
</fC03>
<fN21>
<s1>044</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 06-0073220 BDSP</NO>
<ET>Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</ET>
<AU>DONOSO MANTKE (O.); SCHMITZ (H.); ZELLER (H.); HEYMAN (P.); PAPA (A.); NIEDRIG (M.)</AU>
<DT>Publication en série; Niveau analytique</DT>
<SO>EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY; ISSN 1025-496X; France; Da. 2005-04; Vol. 10; No. 4-6; Pp. 102-106; Bibl. 38 ref.; 3 tabl.</SO>
<LA>Anglais</LA>
<EA>The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)</EA>
<CC>002B30A11</CC>
<FD>Voyage; Virus; Réseau; Surveillance sanitaire; Epidémiologie; Qualité; Sérologie; Biologie clinique; Laboratoire; Europe; Diagnostic; Maladie émergente</FD>
<ED>Travel; Virus; Network; Sanitary surveillance; Epidemiology; Quality; Serology; Clinical biology; Laboratory; Europe; Diagnosis; Emerging disease</ED>
<SD>Viaje; Virus; Red; Vigilancia sanitaria; Epidemiología; Calidad; Serología; Biología clínica; Laboratorio; Europa; Diagnóstico; Enfermedad emergente</SD>
<LO>BDSP/InVS</LO>
<ID>06-0073220</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000557 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000557 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0073220
   |texte=   Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021